Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Bilayer engineered skin composed of keratinocytes from the patient (autologous) and fibroblasts from a donor (allogeneic) embedded in a plasma matrix

EU orphan designation number: EU/3/06/369   
Active ingredient: Bilayer engineered skin composed of keratinocytes from the patient (autologous) and fibroblasts from a donor (allogeneic) embedded in a plasma matrix
Indication: Treatment of epidermolysis bullosa
Sponsor: TiGenix S.A.U.
Marconi 1, Parque Tecnológico de Madrid, E-28760 Tres Cantos, Madrid, España

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/05/2006 Centralised Orphan - Designation EMEA/OD/111/05 (2006)2146 of 22/05/2006
03/08/2006 Corrigendum (2006)2146 of 28/07/2006
18/09/2008 Other procedure
04/02/2013 Other procedure